MCID: IMM005
MIFTS: 24

Immature Teratoma of Ovary

Categories: Reproductive diseases, Rare diseases, Endocrine diseases, Cancer diseases

Aliases & Classifications for Immature Teratoma of Ovary

MalaCards integrated aliases for Immature Teratoma of Ovary:

Name: Immature Teratoma of Ovary 12 59 15 73
Malignant Teratoma of Ovary 12 59
Ovarian Malignant Teratoma 59
Ovarian Immature Teratoma 59

Characteristics:

Orphanet epidemiological data:

59
malignant teratoma of ovary
Age of onset: Adolescent,Adult,Childhood,Infancy;

Classifications:



External Ids:

Disease Ontology 12 DOID:6331
NCIt 50 C8111
SNOMED-CT 68 254871000
Orphanet 59 ORPHA398987
ICD10 via Orphanet 34 C56
UMLS 73 C0346182

Summaries for Immature Teratoma of Ovary

MalaCards based summary : Immature Teratoma of Ovary, also known as malignant teratoma of ovary, is related to childhood immature teratoma of ovary and teratoma. An important gene associated with Immature Teratoma of Ovary is CEACAM5 (Carcinoembryonic Antigen Related Cell Adhesion Molecule 5). The drugs Cisplatin and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include ovary, bone marrow and bone.

Related Diseases for Immature Teratoma of Ovary

Diseases related to Immature Teratoma of Ovary via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 childhood immature teratoma of ovary 12.3
2 teratoma 10.2
3 choroiditis 9.9
4 gliomatosis peritonei 9.9
5 growing teratoma syndrome 9.9
6 embryonal carcinoma 9.8
7 malignant teratoma 9.8

Graphical network of the top 20 diseases related to Immature Teratoma of Ovary:



Diseases related to Immature Teratoma of Ovary

Symptoms & Phenotypes for Immature Teratoma of Ovary

Drugs & Therapeutics for Immature Teratoma of Ovary

Drugs for Immature Teratoma of Ovary (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 75)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
2
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
3
Ribavirin Approved Phase 3 36791-04-5 37542
4
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
5
Captopril Approved Phase 3 62571-86-2 44093
6
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
7
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
8
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
9
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
10
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
11
Palivizumab Approved, Investigational Phase 3 188039-54-5
12
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
13
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
14
Hydroxyitraconazole Phase 3
15 Alkylating Agents Phase 3,Phase 2
16
protease inhibitors Phase 3
17 Steroid Synthesis Inhibitors Phase 3
18 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
19 Cytochrome P-450 CYP3A Inhibitors Phase 3
20 HIV Protease Inhibitors Phase 3
21 Cytochrome P-450 Enzyme Inhibitors Phase 3
22 Topoisomerase Inhibitors Phase 3,Phase 2
23 Hormone Antagonists Phase 3,Phase 1,Phase 2
24 Hormones Phase 3,Phase 1,Phase 2
25 Angiotensin-Converting Enzyme Inhibitors Phase 3
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 1,Phase 2
27 Echinocandins Phase 3
28 Anti-Bacterial Agents Phase 3
29 Antibodies Phase 3,Phase 1
30 Immunoglobulins Phase 3,Phase 1
31 Antibodies, Monoclonal Phase 3,Phase 1
32 Etoposide phosphate Phase 3,Phase 2
33 Antihypertensive Agents Phase 3
34 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
35 Anti-Infective Agents Phase 3,Phase 2
36 Antifungal Agents Phase 3
37 Antiparasitic Agents Phase 3
38 Antiprotozoal Agents Phase 3
39 Liposomal amphotericin B Phase 3
40 Antirheumatic Agents Phase 3
41 Antimetabolites Phase 3
42 Antiviral Agents Phase 3,Phase 2
43 Antimitotic Agents Phase 3,Phase 2
44 Antineoplastic Agents, Alkylating Phase 3,Phase 2
45 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
46 Podophyllotoxin Phase 3 518-28-5
47 Dermatologic Agents Phase 3
48 Antibiotics, Antitubercular Phase 3
49 Keratolytic Agents Phase 3
50
Palbociclib Approved, Investigational Phase 2 571190-30-2 11431660 5005498 5330286

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
2 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
3 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
4 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
5 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
6 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide
7 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Unknown status NCT01037790 Phase 2 PD-0332991
8 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
9 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
10 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
11 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
12 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
13 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
14 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
15 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
16 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Completed NCT00060372 Phase 1 ipilimumab;therapeutic allogeneic lymphocytes
17 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
18 Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Completed NCT00060021 Not Applicable
19 Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer Completed NCT00049465 Not Applicable

Search NIH Clinical Center for Immature Teratoma of Ovary

Genetic Tests for Immature Teratoma of Ovary

Anatomical Context for Immature Teratoma of Ovary

MalaCards organs/tissues related to Immature Teratoma of Ovary:

41
Ovary, Bone Marrow, Bone, Colon, Small Intestine

Publications for Immature Teratoma of Ovary

Articles related to Immature Teratoma of Ovary:

# Title Authors Year
1
Growing Teratoma Syndrome Following Treatment for Immature Teratoma of Ovary-A Case Report and Review of Literature. ( 28706371 )
2017
2
Gliomatosis Peritonei Arising in Setting of Immature Teratoma of Ovary: A Case Report and Review of Literature. ( 27298531 )
2016
3
Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort. ( 26142911 )
2015
4
Immature teratoma of ovary composed largely of choroid plexus. ( 20683425 )
2010

Variations for Immature Teratoma of Ovary

Expression for Immature Teratoma of Ovary

Search GEO for disease gene expression data for Immature Teratoma of Ovary.

Pathways for Immature Teratoma of Ovary

GO Terms for Immature Teratoma of Ovary

Sources for Immature Teratoma of Ovary

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....